Scarica l'app Stockscreener
278.18
0.59%
1.62
Dopo l'orario di chiusura:
276.69
-1.49
-0.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$276.56
Aprire:
$277.9
Volume 24 ore:
481.23K
Relative Volume:
0.69
Capitalizzazione di mercato:
$23.12B
Reddito:
$13.48B
Utile/perdita netta:
$764.50M
Rapporto P/E:
30.70
EPS:
9.06
Flusso di cassa netto:
$1.26B
1 W Prestazione:
+2.88%
1M Prestazione:
+10.36%
6M Prestazione:
+11.34%
1 anno Prestazione:
+20.85%
Intervallo 1D:
$277.27
$280.28
Intervallo di 1 settimana:
$269.68
$280.28
Portata 52W:
$209.38
$283.47
Labcorp Holdings Inc Stock (LH) Company Profile
Nome
Labcorp Holdings Inc
Settore
Industria
Telefono
(336) 229-1127
Indirizzo
358 S MAIN ST, BURLINGTON, NC
Confronta LH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
278.18 | 22.48B | 13.48B | 764.50M | 1.26B | 9.06 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-30 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-10-01 | Iniziato | Piper Sandler | Neutral |
| 2024-03-25 | Aggiornamento | Argus | Hold → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Iniziato | Evercore ISI | In-line |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-19 | Downgrade | Argus | Buy → Hold |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-11 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Ripresa | Deutsche Bank | Buy |
| 2020-05-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-04-29 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2019-07-16 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-30 | Downgrade | Argus | Buy → Hold |
| 2018-10-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Ripresa | BofA/Merrill | Buy |
| 2018-06-07 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Iniziato | Argus | Buy |
Mostra tutto
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock - Yahoo Finance
Can Labcorp Holdings Inc. Escape Recent Bear ChannelCEO Change & Consistent Return Investment Signals - kangso.co.kr
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term - sharewise.com
Labcorp launches FDA-cleared blood test for Alzheimer's disease - MSN
Labcorp Wins ERISA Bench Trial, NextEra to Face Class Action - planadviser
Labcorp Holdings' Lumipulse pTau-217/Beta Amyloid 42 Ratio Launch Enhances Alzheimer's Diagnostics Capabilities, Supporting Revenue Growth - AInvest
Labcorp Holdings (LH) Launches FDA-Cleared Alzheimer's Diagnostic Blood Test Nationwide - Yahoo Finance
Federal Circuit overturns jury win for Labcorp in dispute with Qiagen - BioWorld MedTech
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up - TradingView
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - simplywall.st
Published on: 2025-08-19 00:48:14 - beatles.ru
LabCorp Prevails in ERISA Trial, While Case Against NextEra Allowed to Proceed - plansponsor
Labcorp launches first FDA-cleared blood test for Alzheimer's disease - MarketScreener
Labcorp launches first FDA-cleared blood test for Alzheimer’s disease By Investing.com - Investing.com South Africa
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease - MarketScreener
Labcorp Announces Availability Of Lumipulse PTau-217/Beta Amyloid 42 Ratio For Alzheimer's Diagnosis - Nasdaq
Labcorp Launches First FDA-Cleared Blood Test For Alzheimer's Disease - Barchart.com
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Insider Transactions at Labcorp Holdings: A Balancing Act of Confidence and Caution - AInvest
What makes Labcorp Holdings Inc. stock price move sharply2025 Earnings Impact & Fast Entry High Yield Tips - sundaytimes.kr
Labcorp Executive Makes a Million-Dollar Move! - TipRanks
Labcorp Holdings shares rise 1.66% after-hours following insider share sales. - AInvest
After 3 years, federal judge dismisses 401(k) lawsuit against LabCorp - Pensions & Investments
Labcorp EVP van der Vaart sells $1.06m in shares By Investing.com - Investing.com Australia
LabCorp Fails to Block Natera Patent-Invalidity Claims Pre-Trial - Bloomberg Law News
Labcorp EVP van der Vaart sells $1.06m in shares - Investing.com
Labcorp Holdings Insider Sells Shares Worth $1.06mln in Recent SEC Filing - AInvest
Labcorp Holdings Insider Sold Shares Worth $1,059,371, According to a Recent SEC Filing - MarketScreener
Here's Why Labcorp Holdings (LH) is a Strong Value Stock - Yahoo Finance
Stock Analysis | Labcorp OutlookMixed Signals Amid Analyst Optimism and Weak Technicals - AInvest
Labcorp’s SWOT analysis: diagnostic giant faces PAMA headwinds, stock outlook mixed - Investing.com
Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services - Yahoo Finance
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Machine Learning Models Forecast Labcorp Holdings Inc. Uptick2025 Volatility Report & Fast Gain Swing Alerts - mustnews.co.kr
Quant Funds Rotate Into Labcorp Holdings Inc. StockJuly 2025 Selloffs & Consistent Income Trade Recommendations - sisa-n.com
Labcorp Wins ERISA Trial As Judge Cites Stronger Witnesses - Law360
Labcorp Holdings Short Interest Falls, Signaling Bullish Market Sentiment - AInvest
Labcorp CEO Schechter sells $1.5m in shares By Investing.com - Investing.com Nigeria
Labcorp CEO Schechter sells $1.5m in shares - Investing.com
LabCorp Scores Trial Victory in 401(k) Plan Fee Class Challenge - news.bloombergtax.com
Labcorp Holdings Sees RS Rating Rise To 73 - Investor's Business Daily
Labcorp Holdings: How Non-GAAP Adjustments Reveal a Stronger Earnings Story and a Potentially Undervalued Stock - AInvest
Investing in Labcorp Holdings (NYSE:LH) Five Years Ago Would Have Delivered You a 71% Gain - 富途牛牛
Analysts Have Conflicting Sentiments on These Healthcare Companies: Labcorp Holdings (LH), Bausch + Lomb Corporation (BLCO) and Radnet (RDNT) - The Globe and Mail
What analysts say about Labcorp Holdings Inc. stock outlookAlpha Focused Technical Trade Signals Gain Attention - beatles.ru
Is Labcorp Holdings Inc. a growth stock or a value stockDynamic portfolio growth - Jammu Links News
Is it the right time to buy Labcorp Holdings Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
How strong is Labcorp Holdings Inc. company’s balance sheetHigh-yield growth strategies - Jammu Links News
How many analysts rate Labcorp Holdings Inc. as a “Buy”Free Investment Risk Control - Jammu Links News
Does Labcorp Holdings Inc. stock perform well during market downturnsCapitalize on high-yield stock opportunities - Jammu Links News
When is Labcorp Holdings Inc. stock expected to show significant growthHigh-margin investment plays - Jammu Links News
Labcorp Holdings Inc Azioni (LH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.25%
1.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):